nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—forebrain—epilepsy syndrome	0.0105	0.154	CbGeAlD
Plerixafor—CXCR4—telencephalon—epilepsy syndrome	0.00968	0.141	CbGeAlD
Plerixafor—CXCR4—medulla oblongata—epilepsy syndrome	0.0076	0.111	CbGeAlD
Plerixafor—CXCR4—midbrain—epilepsy syndrome	0.00695	0.101	CbGeAlD
Plerixafor—CXCR4—spinal cord—epilepsy syndrome	0.00678	0.099	CbGeAlD
Plerixafor—CXCR4—head—epilepsy syndrome	0.00603	0.0879	CbGeAlD
Plerixafor—CXCR4—nervous system—epilepsy syndrome	0.00571	0.0834	CbGeAlD
Plerixafor—CXCR4—central nervous system—epilepsy syndrome	0.0055	0.0803	CbGeAlD
Plerixafor—CXCR4—cerebellum—epilepsy syndrome	0.00538	0.0785	CbGeAlD
Plerixafor—CXCR4—brain—epilepsy syndrome	0.00437	0.0637	CbGeAlD
Plerixafor—CXCR4—GPCR ligand binding—CRH—epilepsy syndrome	0.000472	0.0011	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—OXT—epilepsy syndrome	0.000472	0.0011	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCL2—epilepsy syndrome	0.000472	0.0011	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL3—epilepsy syndrome	0.000472	0.0011	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GRM2—epilepsy syndrome	0.000461	0.00108	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.000459	0.00107	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR5—epilepsy syndrome	0.000454	0.00106	CbGpPWpGaD
Plerixafor—CXCR4—Disease—STX1B—epilepsy syndrome	0.000445	0.00104	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.00044	0.00103	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.00044	0.00103	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.00044	0.00103	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR8—epilepsy syndrome	0.00044	0.00103	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR9—epilepsy syndrome	0.00044	0.00103	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GRM4—epilepsy syndrome	0.000431	0.00101	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GRM3—epilepsy syndrome	0.000431	0.00101	CbGpPWpGaD
Plerixafor—Asthenia—Felbamate—epilepsy syndrome	0.000431	0.000855	CcSEcCtD
Plerixafor—Arthralgia—Valproic Acid—epilepsy syndrome	0.00043	0.000854	CcSEcCtD
Plerixafor—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000428	0.000849	CcSEcCtD
Plerixafor—Rash—Midazolam—epilepsy syndrome	0.000428	0.000849	CcSEcCtD
Plerixafor—Dizziness—Fosphenytoin—epilepsy syndrome	0.000427	0.000848	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000427	0.000848	CcSEcCtD
Plerixafor—Dermatitis—Midazolam—epilepsy syndrome	0.000427	0.000848	CcSEcCtD
Plerixafor—Urticaria—Carbamazepine—epilepsy syndrome	0.000427	0.000847	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—SST—epilepsy syndrome	0.000427	0.000997	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR2—epilepsy syndrome	0.000427	0.000997	CbGpPWpGaD
Plerixafor—Vomiting—Levetiracetam—epilepsy syndrome	0.000426	0.000845	CcSEcCtD
Plerixafor—Discomfort—Valproic Acid—epilepsy syndrome	0.000425	0.000844	CcSEcCtD
Plerixafor—Headache—Midazolam—epilepsy syndrome	0.000425	0.000843	CcSEcCtD
Plerixafor—Pruritus—Felbamate—epilepsy syndrome	0.000425	0.000843	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.000424	0.000992	CbGpPWpGaD
Plerixafor—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000424	0.000843	CcSEcCtD
Plerixafor—Diarrhoea—Diazepam—epilepsy syndrome	0.000424	0.000842	CcSEcCtD
Plerixafor—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000424	0.000842	CcSEcCtD
Plerixafor—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000424	0.000841	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.000423	0.00099	CbGpPWpGaD
Plerixafor—Rash—Levetiracetam—epilepsy syndrome	0.000422	0.000838	CcSEcCtD
Plerixafor—Dermatitis—Levetiracetam—epilepsy syndrome	0.000422	0.000837	CcSEcCtD
Plerixafor—Asthenia—Zonisamide—epilepsy syndrome	0.000422	0.000837	CcSEcCtD
Plerixafor—Mental disorder—Gabapentin—epilepsy syndrome	0.000422	0.000837	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—AGT—epilepsy syndrome	0.000422	0.000985	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	0.000421	0.000985	CbGpPWpGaD
Plerixafor—Dry mouth—Valproic Acid—epilepsy syndrome	0.000421	0.000835	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—POMC—epilepsy syndrome	0.000421	0.000983	CbGpPWpGaD
Plerixafor—Headache—Levetiracetam—epilepsy syndrome	0.00042	0.000833	CcSEcCtD
Plerixafor—Erythema—Gabapentin—epilepsy syndrome	0.000419	0.000832	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000417	0.000976	CbGpPWpGaD
Plerixafor—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000417	0.000828	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—SSTR3—epilepsy syndrome	0.000417	0.000974	CbGpPWpGaD
Plerixafor—Dizziness—Vigabatrin—epilepsy syndrome	0.000417	0.000827	CcSEcCtD
Plerixafor—Pruritus—Zonisamide—epilepsy syndrome	0.000416	0.000825	CcSEcCtD
Plerixafor—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000414	0.000823	CcSEcCtD
Plerixafor—CXCR4—Disease—GBE1—epilepsy syndrome	0.000413	0.000966	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PPP1R3C—epilepsy syndrome	0.000413	0.000966	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CPSF4—epilepsy syndrome	0.000413	0.000966	CbGpPWpGaD
Plerixafor—Flatulence—Gabapentin—epilepsy syndrome	0.000413	0.000819	CcSEcCtD
Plerixafor—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000412	0.000819	CcSEcCtD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	0.000412	0.000964	CbGpPWpGaD
Plerixafor—Urticaria—Lamotrigine—epilepsy syndrome	0.000412	0.000818	CcSEcCtD
Plerixafor—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000412	0.000818	CcSEcCtD
Plerixafor—Malaise—Pregabalin—epilepsy syndrome	0.000412	0.000818	CcSEcCtD
Plerixafor—Nausea—Propofol—epilepsy syndrome	0.000412	0.000817	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL2—epilepsy syndrome	0.000411	0.000962	CbGpPWpGaD
Plerixafor—Vomiting—Fosphenytoin—epilepsy syndrome	0.000411	0.000816	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000411	0.00096	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRDM4—epilepsy syndrome	0.000411	0.00096	CbGpPWpGaD
Plerixafor—Diarrhoea—Felbamate—epilepsy syndrome	0.000411	0.000815	CcSEcCtD
Plerixafor—Abdominal pain—Lamotrigine—epilepsy syndrome	0.00041	0.000814	CcSEcCtD
Plerixafor—Dizziness—Diazepam—epilepsy syndrome	0.00041	0.000814	CcSEcCtD
Plerixafor—Syncope—Pregabalin—epilepsy syndrome	0.00041	0.000813	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—GRM8—epilepsy syndrome	0.000409	0.000956	CbGpPWpGaD
Plerixafor—Rash—Fosphenytoin—epilepsy syndrome	0.000407	0.000809	CcSEcCtD
Plerixafor—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000407	0.000808	CcSEcCtD
Plerixafor—Haemoglobin—Topiramate—epilepsy syndrome	0.000407	0.000808	CcSEcCtD
Plerixafor—Asthenia—Clonazepam—epilepsy syndrome	0.000406	0.000807	CcSEcCtD
Plerixafor—Headache—Fosphenytoin—epilepsy syndrome	0.000405	0.000804	CcSEcCtD
Plerixafor—Haemorrhage—Topiramate—epilepsy syndrome	0.000405	0.000804	CcSEcCtD
Plerixafor—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000404	0.000803	CcSEcCtD
Plerixafor—Asthenia—Phenytoin—epilepsy syndrome	0.000404	0.000801	CcSEcCtD
Plerixafor—Nausea—Midazolam—epilepsy syndrome	0.000403	0.0008	CcSEcCtD
Plerixafor—Diarrhoea—Zonisamide—epilepsy syndrome	0.000402	0.000798	CcSEcCtD
Plerixafor—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000401	0.000797	CcSEcCtD
Plerixafor—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000401	0.000797	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CXCL12—epilepsy syndrome	0.000401	0.000937	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.000401	0.000937	CbGpPWpGaD
Plerixafor—Pruritus—Clonazepam—epilepsy syndrome	0.000401	0.000795	CcSEcCtD
Plerixafor—Vomiting—Vigabatrin—epilepsy syndrome	0.000401	0.000795	CcSEcCtD
Plerixafor—Skin disorder—Valproic Acid—epilepsy syndrome	0.000401	0.000795	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.000399	0.000934	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR8—epilepsy syndrome	0.000399	0.000934	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—NPY2R—epilepsy syndrome	0.000399	0.000934	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR9—epilepsy syndrome	0.000399	0.000934	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—SSTR1—epilepsy syndrome	0.000399	0.000934	CbGpPWpGaD
Plerixafor—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000399	0.000791	CcSEcCtD
Plerixafor—Pruritus—Phenytoin—epilepsy syndrome	0.000398	0.00079	CcSEcCtD
Plerixafor—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000398	0.00079	CcSEcCtD
Plerixafor—Nausea—Levetiracetam—epilepsy syndrome	0.000398	0.00079	CcSEcCtD
Plerixafor—Rash—Vigabatrin—epilepsy syndrome	0.000397	0.000789	CcSEcCtD
Plerixafor—Dizziness—Felbamate—epilepsy syndrome	0.000397	0.000788	CcSEcCtD
Plerixafor—Dermatitis—Vigabatrin—epilepsy syndrome	0.000397	0.000788	CcSEcCtD
Plerixafor—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000396	0.000786	CcSEcCtD
Plerixafor—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000396	0.000785	CcSEcCtD
Plerixafor—Headache—Vigabatrin—epilepsy syndrome	0.000395	0.000784	CcSEcCtD
Plerixafor—Vomiting—Diazepam—epilepsy syndrome	0.000394	0.000783	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CNR1—epilepsy syndrome	0.000394	0.00092	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	0.000393	0.000918	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GRM3—epilepsy syndrome	0.000392	0.000916	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GRM4—epilepsy syndrome	0.000392	0.000916	CbGpPWpGaD
Plerixafor—Rash—Diazepam—epilepsy syndrome	0.000391	0.000776	CcSEcCtD
Plerixafor—Dermatitis—Diazepam—epilepsy syndrome	0.000391	0.000776	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.00039	0.000912	CbGpPWpGaD
Plerixafor—Arthralgia—Pregabalin—epilepsy syndrome	0.000389	0.000772	CcSEcCtD
Plerixafor—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000389	0.000772	CcSEcCtD
Plerixafor—Dizziness—Zonisamide—epilepsy syndrome	0.000389	0.000771	CcSEcCtD
Plerixafor—Headache—Diazepam—epilepsy syndrome	0.000389	0.000771	CcSEcCtD
Plerixafor—Diarrhoea—Clonazepam—epilepsy syndrome	0.000387	0.000769	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000386	0.000767	CcSEcCtD
Plerixafor—Asthenia—Carbamazepine—epilepsy syndrome	0.000385	0.000765	CcSEcCtD
Plerixafor—Diarrhoea—Phenytoin—epilepsy syndrome	0.000385	0.000764	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—SSTR2—epilepsy syndrome	0.000385	0.000899	CbGpPWpGaD
Plerixafor—Discomfort—Pregabalin—epilepsy syndrome	0.000384	0.000763	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—HTR7—epilepsy syndrome	0.000384	0.000898	CbGpPWpGaD
Plerixafor—Nausea—Fosphenytoin—epilepsy syndrome	0.000384	0.000762	CcSEcCtD
Plerixafor—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000383	0.00076	CcSEcCtD
Plerixafor—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000382	0.000759	CcSEcCtD
Plerixafor—Vomiting—Felbamate—epilepsy syndrome	0.000382	0.000758	CcSEcCtD
Plerixafor—Dry mouth—Pregabalin—epilepsy syndrome	0.00038	0.000755	CcSEcCtD
Plerixafor—Pruritus—Carbamazepine—epilepsy syndrome	0.00038	0.000754	CcSEcCtD
Plerixafor—Rash—Felbamate—epilepsy syndrome	0.000378	0.000751	CcSEcCtD
Plerixafor—Dermatitis—Felbamate—epilepsy syndrome	0.000378	0.000751	CcSEcCtD
Plerixafor—Malaise—Gabapentin—epilepsy syndrome	0.000378	0.00075	CcSEcCtD
Plerixafor—Headache—Felbamate—epilepsy syndrome	0.000376	0.000747	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000376	0.000746	CcSEcCtD
Plerixafor—Syncope—Gabapentin—epilepsy syndrome	0.000376	0.000746	CcSEcCtD
Plerixafor—Dizziness—Clonazepam—epilepsy syndrome	0.000374	0.000743	CcSEcCtD
Plerixafor—Nausea—Vigabatrin—epilepsy syndrome	0.000374	0.000743	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CCR7—epilepsy syndrome	0.000374	0.000874	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PDYN—epilepsy syndrome	0.000374	0.000874	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GRM1—epilepsy syndrome	0.000374	0.000874	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.000374	0.000874	CbGpPWpGaD
Plerixafor—Vomiting—Zonisamide—epilepsy syndrome	0.000374	0.000742	CcSEcCtD
Plerixafor—Insomnia—Valproic Acid—epilepsy syndrome	0.000373	0.00074	CcSEcCtD
Plerixafor—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000373	0.00074	CcSEcCtD
Plerixafor—Asthenia—Lamotrigine—epilepsy syndrome	0.000372	0.000739	CcSEcCtD
Plerixafor—Dizziness—Phenytoin—epilepsy syndrome	0.000372	0.000738	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—GRM8—epilepsy syndrome	0.000371	0.000868	CbGpPWpGaD
Plerixafor—Rash—Zonisamide—epilepsy syndrome	0.00037	0.000736	CcSEcCtD
Plerixafor—Paraesthesia—Valproic Acid—epilepsy syndrome	0.00037	0.000735	CcSEcCtD
Plerixafor—Dermatitis—Zonisamide—epilepsy syndrome	0.00037	0.000735	CcSEcCtD
Plerixafor—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00037	0.000735	CcSEcCtD
Plerixafor—Nausea—Diazepam—epilepsy syndrome	0.000368	0.000731	CcSEcCtD
Plerixafor—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000368	0.000731	CcSEcCtD
Plerixafor—Headache—Zonisamide—epilepsy syndrome	0.000368	0.000731	CcSEcCtD
Plerixafor—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000368	0.00073	CcSEcCtD
Plerixafor—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000367	0.000729	CcSEcCtD
Plerixafor—Pruritus—Lamotrigine—epilepsy syndrome	0.000367	0.000729	CcSEcCtD
Plerixafor—Shock—Pregabalin—epilepsy syndrome	0.000367	0.000728	CcSEcCtD
Plerixafor—Immune system disorder—Topiramate—epilepsy syndrome	0.000366	0.000726	CcSEcCtD
Plerixafor—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000366	0.000726	CcSEcCtD
Plerixafor—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000363	0.000721	CcSEcCtD
Plerixafor—Skin disorder—Pregabalin—epilepsy syndrome	0.000362	0.000719	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.000361	0.000844	CbGpPWpGaD
Plerixafor—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.00036	0.000715	CcSEcCtD
Plerixafor—Vomiting—Clonazepam—epilepsy syndrome	0.00036	0.000715	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—ACKR4—epilepsy syndrome	0.000359	0.00084	CbGpPWpGaD
Plerixafor—Vomiting—Phenytoin—epilepsy syndrome	0.000358	0.00071	CcSEcCtD
Plerixafor—Rash—Clonazepam—epilepsy syndrome	0.000357	0.000709	CcSEcCtD
Plerixafor—Dermatitis—Clonazepam—epilepsy syndrome	0.000357	0.000708	CcSEcCtD
Plerixafor—Arthralgia—Gabapentin—epilepsy syndrome	0.000357	0.000708	CcSEcCtD
Plerixafor—Nausea—Felbamate—epilepsy syndrome	0.000357	0.000708	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000356	0.000707	CcSEcCtD
Plerixafor—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000356	0.000706	CcSEcCtD
Plerixafor—Fatigue—Valproic Acid—epilepsy syndrome	0.000356	0.000706	CcSEcCtD
Plerixafor—Dizziness—Carbamazepine—epilepsy syndrome	0.000355	0.000705	CcSEcCtD
Plerixafor—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000355	0.000705	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—POMC—epilepsy syndrome	0.000355	0.000829	CbGpPWpGaD
Plerixafor—Headache—Clonazepam—epilepsy syndrome	0.000355	0.000704	CcSEcCtD
Plerixafor—Rash—Phenytoin—epilepsy syndrome	0.000355	0.000704	CcSEcCtD
Plerixafor—Mental disorder—Topiramate—epilepsy syndrome	0.000355	0.000704	CcSEcCtD
Plerixafor—Dermatitis—Phenytoin—epilepsy syndrome	0.000354	0.000703	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000354	0.000828	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000354	0.000828	CbGpPWpGaD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000354	0.000703	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000353	0.000826	CbGpPWpGaD
Plerixafor—Rash—Oxcarbazepine—epilepsy syndrome	0.000353	0.0007	CcSEcCtD
Plerixafor—Constipation—Valproic Acid—epilepsy syndrome	0.000353	0.0007	CcSEcCtD
Plerixafor—Pain—Valproic Acid—epilepsy syndrome	0.000353	0.0007	CcSEcCtD
Plerixafor—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000352	0.0007	CcSEcCtD
Plerixafor—Headache—Phenytoin—epilepsy syndrome	0.000352	0.0007	CcSEcCtD
Plerixafor—Erythema—Topiramate—epilepsy syndrome	0.000352	0.0007	CcSEcCtD
Plerixafor—Discomfort—Gabapentin—epilepsy syndrome	0.000352	0.000699	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—GAL—epilepsy syndrome	0.000352	0.000822	CbGpPWpGaD
Plerixafor—Headache—Oxcarbazepine—epilepsy syndrome	0.000351	0.000696	CcSEcCtD
Plerixafor—Nausea—Zonisamide—epilepsy syndrome	0.000349	0.000693	CcSEcCtD
Plerixafor—Dry mouth—Gabapentin—epilepsy syndrome	0.000349	0.000692	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—GRM5—epilepsy syndrome	0.000348	0.000813	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.000348	0.000813	CbGpPWpGaD
Plerixafor—Flatulence—Topiramate—epilepsy syndrome	0.000347	0.000689	CcSEcCtD
Plerixafor—CXCR4—Disease—ST3GAL3—epilepsy syndrome	0.000344	0.000804	CbGpPWpGaD
Plerixafor—Dizziness—Lamotrigine—epilepsy syndrome	0.000343	0.000681	CcSEcCtD
Plerixafor—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000342	0.000679	CcSEcCtD
Plerixafor—Vomiting—Carbamazepine—epilepsy syndrome	0.000341	0.000678	CcSEcCtD
Plerixafor—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.00034	0.000675	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCR7—epilepsy syndrome	0.00034	0.000794	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PDYN—epilepsy syndrome	0.00034	0.000794	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GRM1—epilepsy syndrome	0.00034	0.000794	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CHRM1—epilepsy syndrome	0.00034	0.000794	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.00034	0.000674	CcSEcCtD
Plerixafor—Rash—Carbamazepine—epilepsy syndrome	0.000339	0.000672	CcSEcCtD
Plerixafor—Dermatitis—Carbamazepine—epilepsy syndrome	0.000338	0.000671	CcSEcCtD
Plerixafor—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000337	0.000669	CcSEcCtD
Plerixafor—Insomnia—Pregabalin—epilepsy syndrome	0.000337	0.000669	CcSEcCtD
Plerixafor—Nausea—Clonazepam—epilepsy syndrome	0.000336	0.000668	CcSEcCtD
Plerixafor—Headache—Carbamazepine—epilepsy syndrome	0.000336	0.000668	CcSEcCtD
Plerixafor—Shock—Gabapentin—epilepsy syndrome	0.000336	0.000668	CcSEcCtD
Plerixafor—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000335	0.000666	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000335	0.000783	CbGpPWpGaD
Plerixafor—Paraesthesia—Pregabalin—epilepsy syndrome	0.000335	0.000665	CcSEcCtD
Plerixafor—Nausea—Phenytoin—epilepsy syndrome	0.000334	0.000663	CcSEcCtD
Plerixafor—Dyspnoea—Pregabalin—epilepsy syndrome	0.000332	0.00066	CcSEcCtD
Plerixafor—Nausea—Oxcarbazepine—epilepsy syndrome	0.000332	0.00066	CcSEcCtD
Plerixafor—Skin disorder—Gabapentin—epilepsy syndrome	0.000332	0.000659	CcSEcCtD
Plerixafor—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.00033	0.000656	CcSEcCtD
Plerixafor—Vomiting—Lamotrigine—epilepsy syndrome	0.00033	0.000655	CcSEcCtD
Plerixafor—Urticaria—Valproic Acid—epilepsy syndrome	0.000328	0.00065	CcSEcCtD
Plerixafor—Rash—Lamotrigine—epilepsy syndrome	0.000327	0.00065	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000327	0.000764	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000327	0.000764	CbGpPWpGaD
Plerixafor—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000327	0.000649	CcSEcCtD
Plerixafor—Dermatitis—Lamotrigine—epilepsy syndrome	0.000327	0.000649	CcSEcCtD
Plerixafor—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000326	0.000647	CcSEcCtD
Plerixafor—Headache—Lamotrigine—epilepsy syndrome	0.000325	0.000645	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—SSTR4—epilepsy syndrome	0.000325	0.000759	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SSTR5—epilepsy syndrome	0.000325	0.000759	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—AKT1—epilepsy syndrome	0.000324	0.000757	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—AVP—epilepsy syndrome	0.000323	0.000756	CbGpPWpGaD
Plerixafor—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000322	0.000639	CcSEcCtD
Plerixafor—Fatigue—Pregabalin—epilepsy syndrome	0.000321	0.000638	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—GAL—epilepsy syndrome	0.000319	0.000747	CbGpPWpGaD
Plerixafor—Nausea—Carbamazepine—epilepsy syndrome	0.000319	0.000633	CcSEcCtD
Plerixafor—Pain—Pregabalin—epilepsy syndrome	0.000319	0.000633	CcSEcCtD
Plerixafor—Constipation—Pregabalin—epilepsy syndrome	0.000319	0.000633	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000318	0.000743	CbGpPWpGaD
Plerixafor—Malaise—Topiramate—epilepsy syndrome	0.000318	0.000631	CcSEcCtD
Plerixafor—Syncope—Topiramate—epilepsy syndrome	0.000316	0.000627	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—GRM5—epilepsy syndrome	0.000316	0.000738	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000316	0.000738	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000311	0.000618	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCR10—epilepsy syndrome	0.000311	0.000728	CbGpPWpGaD
Plerixafor—Loss of consciousness—Topiramate—epilepsy syndrome	0.00031	0.000615	CcSEcCtD
Plerixafor—Insomnia—Gabapentin—epilepsy syndrome	0.000309	0.000614	CcSEcCtD
Plerixafor—Nausea—Lamotrigine—epilepsy syndrome	0.000308	0.000612	CcSEcCtD
Plerixafor—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000307	0.00061	CcSEcCtD
Plerixafor—Paraesthesia—Gabapentin—epilepsy syndrome	0.000307	0.000609	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000305	0.000713	CbGpPWpGaD
Plerixafor—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000305	0.000605	CcSEcCtD
Plerixafor—Dyspnoea—Gabapentin—epilepsy syndrome	0.000305	0.000605	CcSEcCtD
Plerixafor—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000304	0.000603	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000303	0.000708	CbGpPWpGaD
Plerixafor—Dyspepsia—Gabapentin—epilepsy syndrome	0.000301	0.000597	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.0003	0.000702	CbGpPWpGaD
Plerixafor—Arthralgia—Topiramate—epilepsy syndrome	0.0003	0.000596	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000298	0.000592	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000297	0.000694	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000297	0.000694	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000297	0.000694	CbGpPWpGaD
Plerixafor—Discomfort—Topiramate—epilepsy syndrome	0.000296	0.000588	CcSEcCtD
Plerixafor—Urticaria—Pregabalin—epilepsy syndrome	0.000296	0.000588	CcSEcCtD
Plerixafor—Asthenia—Valproic Acid—epilepsy syndrome	0.000296	0.000587	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000295	0.000586	CcSEcCtD
Plerixafor—Fatigue—Gabapentin—epilepsy syndrome	0.000295	0.000585	CcSEcCtD
Plerixafor—Abdominal pain—Pregabalin—epilepsy syndrome	0.000295	0.000585	CcSEcCtD
Plerixafor—Dry mouth—Topiramate—epilepsy syndrome	0.000293	0.000583	CcSEcCtD
Plerixafor—Constipation—Gabapentin—epilepsy syndrome	0.000292	0.00058	CcSEcCtD
Plerixafor—Pain—Gabapentin—epilepsy syndrome	0.000292	0.00058	CcSEcCtD
Plerixafor—Pruritus—Valproic Acid—epilepsy syndrome	0.000292	0.000579	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000289	0.000675	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000283	0.000663	CbGpPWpGaD
Plerixafor—Shock—Topiramate—epilepsy syndrome	0.000283	0.000562	CcSEcCtD
Plerixafor—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000282	0.00056	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000282	0.000659	CbGpPWpGaD
Plerixafor—Nervous system disorder—Topiramate—epilepsy syndrome	0.000282	0.00056	CcSEcCtD
Plerixafor—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000282	0.000559	CcSEcCtD
Plerixafor—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.00028	0.000555	CcSEcCtD
Plerixafor—Skin disorder—Topiramate—epilepsy syndrome	0.000279	0.000555	CcSEcCtD
Plerixafor—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000278	0.000552	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—HRH3—epilepsy syndrome	0.000277	0.000647	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—NPY—epilepsy syndrome	0.000276	0.000646	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000276	0.000645	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR5—epilepsy syndrome	0.000275	0.000642	CbGpPWpGaD
Plerixafor—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000275	0.000545	CcSEcCtD
Plerixafor—Dizziness—Valproic Acid—epilepsy syndrome	0.000273	0.000541	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000273	0.000637	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GRM2—epilepsy syndrome	0.000272	0.000636	CbGpPWpGaD
Plerixafor—Urticaria—Gabapentin—epilepsy syndrome	0.000272	0.000539	CcSEcCtD
Plerixafor—Abdominal pain—Gabapentin—epilepsy syndrome	0.00027	0.000536	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000269	0.000629	CbGpPWpGaD
Plerixafor—Asthenia—Pregabalin—epilepsy syndrome	0.000267	0.000531	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CRH—epilepsy syndrome	0.000267	0.000623	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000267	0.000623	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—OXT—epilepsy syndrome	0.000267	0.000623	CbGpPWpGaD
Plerixafor—Pruritus—Pregabalin—epilepsy syndrome	0.000264	0.000524	CcSEcCtD
Plerixafor—Vomiting—Valproic Acid—epilepsy syndrome	0.000262	0.000521	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000262	0.00052	CcSEcCtD
Plerixafor—Insomnia—Topiramate—epilepsy syndrome	0.00026	0.000516	CcSEcCtD
Plerixafor—Rash—Valproic Acid—epilepsy syndrome	0.00026	0.000516	CcSEcCtD
Plerixafor—Dermatitis—Valproic Acid—epilepsy syndrome	0.00026	0.000516	CcSEcCtD
Plerixafor—Headache—Valproic Acid—epilepsy syndrome	0.000258	0.000513	CcSEcCtD
Plerixafor—Paraesthesia—Topiramate—epilepsy syndrome	0.000258	0.000513	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCR3—epilepsy syndrome	0.000257	0.000602	CbGpPWpGaD
Plerixafor—Dyspnoea—Topiramate—epilepsy syndrome	0.000256	0.000509	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—AGT—epilepsy syndrome	0.000255	0.000597	CbGpPWpGaD
Plerixafor—Diarrhoea—Pregabalin—epilepsy syndrome	0.000255	0.000506	CcSEcCtD
Plerixafor—Dyspepsia—Topiramate—epilepsy syndrome	0.000253	0.000503	CcSEcCtD
Plerixafor—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000252	0.0005	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—NPY—epilepsy syndrome	0.000251	0.000586	CbGpPWpGaD
Plerixafor—CXCR4—Disease—EIF2AK2—epilepsy syndrome	0.00025	0.000585	CbGpPWpGaD
Plerixafor—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000248	0.000493	CcSEcCtD
Plerixafor—Fatigue—Topiramate—epilepsy syndrome	0.000248	0.000492	CcSEcCtD
Plerixafor—Dizziness—Pregabalin—epilepsy syndrome	0.000247	0.000489	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—SSTR3—epilepsy syndrome	0.000246	0.000575	CbGpPWpGaD
Plerixafor—Constipation—Topiramate—epilepsy syndrome	0.000246	0.000488	CcSEcCtD
Plerixafor—Pain—Topiramate—epilepsy syndrome	0.000246	0.000488	CcSEcCtD
Plerixafor—Asthenia—Gabapentin—epilepsy syndrome	0.000245	0.000487	CcSEcCtD
Plerixafor—Nausea—Valproic Acid—epilepsy syndrome	0.000245	0.000486	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—OXT—epilepsy syndrome	0.000242	0.000566	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL3—epilepsy syndrome	0.000242	0.000566	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CRH—epilepsy syndrome	0.000242	0.000566	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000242	0.000566	CbGpPWpGaD
Plerixafor—Pruritus—Gabapentin—epilepsy syndrome	0.000242	0.00048	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000241	0.000563	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—SST—epilepsy syndrome	0.000241	0.000563	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000241	0.000563	CbGpPWpGaD
Plerixafor—Vomiting—Pregabalin—epilepsy syndrome	0.000237	0.000471	CcSEcCtD
Plerixafor—Feeling abnormal—Topiramate—epilepsy syndrome	0.000237	0.000471	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000236	0.000552	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SSTR1—epilepsy syndrome	0.000236	0.000552	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPY2R—epilepsy syndrome	0.000236	0.000552	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR9—epilepsy syndrome	0.000236	0.000552	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR8—epilepsy syndrome	0.000236	0.000552	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000236	0.000551	CbGpPWpGaD
Plerixafor—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000235	0.000467	CcSEcCtD
Plerixafor—Rash—Pregabalin—epilepsy syndrome	0.000235	0.000467	CcSEcCtD
Plerixafor—Dermatitis—Pregabalin—epilepsy syndrome	0.000235	0.000466	CcSEcCtD
Plerixafor—Diarrhoea—Gabapentin—epilepsy syndrome	0.000234	0.000464	CcSEcCtD
Plerixafor—Headache—Pregabalin—epilepsy syndrome	0.000234	0.000464	CcSEcCtD
Plerixafor—CXCR4—Disease—PPIA—epilepsy syndrome	0.000232	0.000542	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GRM4—epilepsy syndrome	0.000231	0.000541	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GRM3—epilepsy syndrome	0.000231	0.000541	CbGpPWpGaD
Plerixafor—Urticaria—Topiramate—epilepsy syndrome	0.000228	0.000454	CcSEcCtD
Plerixafor—Abdominal pain—Topiramate—epilepsy syndrome	0.000227	0.000451	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—DUSP4—epilepsy syndrome	0.000227	0.000531	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SSTR2—epilepsy syndrome	0.000227	0.000531	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000227	0.00053	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000227	0.00053	CbGpPWpGaD
Plerixafor—Dizziness—Gabapentin—epilepsy syndrome	0.000226	0.000449	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000222	0.00052	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000222	0.000518	CbGpPWpGaD
Plerixafor—Nausea—Pregabalin—epilepsy syndrome	0.000221	0.00044	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—PGF—epilepsy syndrome	0.000219	0.000513	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GRM8—epilepsy syndrome	0.000219	0.000513	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—SST—epilepsy syndrome	0.000219	0.000512	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR2—epilepsy syndrome	0.000219	0.000512	CbGpPWpGaD
Plerixafor—Vomiting—Gabapentin—epilepsy syndrome	0.000217	0.000432	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000217	0.000507	CbGpPWpGaD
Plerixafor—Rash—Gabapentin—epilepsy syndrome	0.000216	0.000428	CcSEcCtD
Plerixafor—Dermatitis—Gabapentin—epilepsy syndrome	0.000215	0.000428	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—POMC—epilepsy syndrome	0.000215	0.000502	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000214	0.000501	CbGpPWpGaD
Plerixafor—Headache—Gabapentin—epilepsy syndrome	0.000214	0.000425	CcSEcCtD
Plerixafor—Hypersensitivity—Topiramate—epilepsy syndrome	0.000212	0.000421	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CCL2—epilepsy syndrome	0.00021	0.000491	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GNAO1—epilepsy syndrome	0.000209	0.000489	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—OPRD1—epilepsy syndrome	0.000209	0.000489	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000207	0.000483	CbGpPWpGaD
Plerixafor—Asthenia—Topiramate—epilepsy syndrome	0.000206	0.00041	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000206	0.000481	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000206	0.000481	CbGpPWpGaD
Plerixafor—Pruritus—Topiramate—epilepsy syndrome	0.000203	0.000404	CcSEcCtD
Plerixafor—Nausea—Gabapentin—epilepsy syndrome	0.000203	0.000403	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CNR1—epilepsy syndrome	0.000202	0.000472	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000201	0.00047	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PDYN—epilepsy syndrome	0.000201	0.000469	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GRM1—epilepsy syndrome	0.000201	0.000469	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR7—epilepsy syndrome	0.000201	0.000469	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CHRM1—epilepsy syndrome	0.000201	0.000469	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR7—epilepsy syndrome	0.000197	0.000461	CbGpPWpGaD
Plerixafor—Diarrhoea—Topiramate—epilepsy syndrome	0.000197	0.000391	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000191	0.000447	CbGpPWpGaD
Plerixafor—Dizziness—Topiramate—epilepsy syndrome	0.00019	0.000378	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000189	0.000441	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GAL—epilepsy syndrome	0.000189	0.000441	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GFAP—epilepsy syndrome	0.000189	0.000441	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AKT3—epilepsy syndrome	0.000188	0.000439	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CASP2—epilepsy syndrome	0.000187	0.000436	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CHRM3—epilepsy syndrome	0.000187	0.000436	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GRM5—epilepsy syndrome	0.000187	0.000436	CbGpPWpGaD
Plerixafor—Vomiting—Topiramate—epilepsy syndrome	0.000183	0.000363	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—AVP—epilepsy syndrome	0.000183	0.000427	CbGpPWpGaD
Plerixafor—Rash—Topiramate—epilepsy syndrome	0.000181	0.00036	CcSEcCtD
Plerixafor—Dermatitis—Topiramate—epilepsy syndrome	0.000181	0.00036	CcSEcCtD
Plerixafor—Headache—Topiramate—epilepsy syndrome	0.00018	0.000358	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000179	0.000418	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000175	0.00041	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000175	0.00041	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CHRM2—epilepsy syndrome	0.000175	0.00041	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SLC2A1—epilepsy syndrome	0.000172	0.000401	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CDC42—epilepsy syndrome	0.000171	0.000401	CbGpPWpGaD
Plerixafor—Nausea—Topiramate—epilepsy syndrome	0.000171	0.000339	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—GABBR1—epilepsy syndrome	0.000171	0.000399	CbGpPWpGaD
Plerixafor—CXCR4—Disease—JUNB—epilepsy syndrome	0.00017	0.000398	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS1—epilepsy syndrome	0.000169	0.000395	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AVP—epilepsy syndrome	0.000166	0.000388	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HRH3—epilepsy syndrome	0.000164	0.000382	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HBEGF—epilepsy syndrome	0.000161	0.000377	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—OPRM1—epilepsy syndrome	0.000161	0.000376	CbGpPWpGaD
Plerixafor—CXCR4—Disease—AKT3—epilepsy syndrome	0.000158	0.00037	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000155	0.000363	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ADAM10—epilepsy syndrome	0.000155	0.000362	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR3—epilepsy syndrome	0.000152	0.000355	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000152	0.000355	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000148	0.000346	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPY—epilepsy syndrome	0.000148	0.000346	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CDC42—epilepsy syndrome	0.000145	0.000338	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AGT—epilepsy syndrome	0.000144	0.000337	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL3—epilepsy syndrome	0.000143	0.000334	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HSPB1—epilepsy syndrome	0.000143	0.000334	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—OXT—epilepsy syndrome	0.000143	0.000334	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL2—epilepsy syndrome	0.000143	0.000334	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CRH—epilepsy syndrome	0.000143	0.000334	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR5—epilepsy syndrome	0.000141	0.00033	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000138	0.000323	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000133	0.000312	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TSC1—epilepsy syndrome	0.000133	0.000311	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PTK2B—epilepsy syndrome	0.000133	0.000311	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HES1—epilepsy syndrome	0.000132	0.000309	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AGT—epilepsy syndrome	0.000131	0.000306	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR2—epilepsy syndrome	0.000129	0.000302	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SST—epilepsy syndrome	0.000129	0.000302	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NTRK2—epilepsy syndrome	0.000129	0.000302	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FYN—epilepsy syndrome	0.000129	0.000301	CbGpPWpGaD
Plerixafor—CXCR4—Disease—H2AFX—epilepsy syndrome	0.000128	0.0003	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—DUSP6—epilepsy syndrome	0.000128	0.0003	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000127	0.000296	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PLAT—epilepsy syndrome	0.000126	0.000295	CbGpPWpGaD
Plerixafor—CXCR4—Disease—YWHAZ—epilepsy syndrome	0.000124	0.000289	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL12—epilepsy syndrome	0.000122	0.000284	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000122	0.000284	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—POMC—epilepsy syndrome	0.000121	0.000284	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000121	0.000283	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000121	0.000282	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—JUNB—epilepsy syndrome	0.000119	0.000279	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CNR1—epilepsy syndrome	0.000119	0.000279	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CCR5—epilepsy syndrome	0.000119	0.000278	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PLCB1—epilepsy syndrome	0.000119	0.000278	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR7—epilepsy syndrome	0.000116	0.000272	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HBEGF—epilepsy syndrome	0.000113	0.000264	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AKT3—epilepsy syndrome	0.000111	0.000259	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TSC2—epilepsy syndrome	0.000111	0.000259	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—POMC—epilepsy syndrome	0.00011	0.000258	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADAM10—epilepsy syndrome	0.000108	0.000253	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOE—epilepsy syndrome	0.000108	0.000253	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL2—epilepsy syndrome	0.000108	0.000252	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—S100B—epilepsy syndrome	0.000102	0.00024	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6ST—epilepsy syndrome	0.000102	0.000238	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SOCS3—epilepsy syndrome	0.000101	0.000237	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CDC42—epilepsy syndrome	0.000101	0.000237	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS2—epilepsy syndrome	0.000101	0.000236	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AVP—epilepsy syndrome	9.8e-05	0.000229	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HES1—epilepsy syndrome	9.27e-05	0.000217	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FYN—epilepsy syndrome	9.01e-05	0.000211	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—H2AFX—epilepsy syndrome	8.98e-05	0.00021	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MEF2C—epilepsy syndrome	8.96e-05	0.00021	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—YWHAZ—epilepsy syndrome	8.66e-05	0.000202	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NGF—epilepsy syndrome	8.57e-05	0.0002	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR5—epilepsy syndrome	8.33e-05	0.000195	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FGF2—epilepsy syndrome	8.22e-05	0.000192	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR2A—epilepsy syndrome	8.15e-05	0.000191	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TSC2—epilepsy syndrome	7.75e-05	0.000181	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AGT—epilepsy syndrome	7.74e-05	0.000181	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOE—epilepsy syndrome	7.58e-05	0.000177	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MTOR—epilepsy syndrome	7.49e-05	0.000175	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—KDR—epilepsy syndrome	7.43e-05	0.000174	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTGS2—epilepsy syndrome	7.42e-05	0.000173	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKCB—epilepsy syndrome	7.15e-05	0.000167	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6ST—epilepsy syndrome	7.12e-05	0.000166	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—POMC—epilepsy syndrome	6.51e-05	0.000152	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL2—epilepsy syndrome	6.37e-05	0.000149	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SRC—epilepsy syndrome	6e-05	0.00014	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FGF2—epilepsy syndrome	5.76e-05	0.000135	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RELA—epilepsy syndrome	5.35e-05	0.000125	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MTOR—epilepsy syndrome	5.24e-05	0.000123	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AKT1—epilepsy syndrome	4.87e-05	0.000114	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CASP3—epilepsy syndrome	4.82e-05	0.000113	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—JUN—epilepsy syndrome	4.68e-05	0.000109	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MMP9—epilepsy syndrome	4.56e-05	0.000107	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AKT1—epilepsy syndrome	4.42e-05	0.000103	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SRC—epilepsy syndrome	4.2e-05	9.82e-05	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VEGFA—epilepsy syndrome	4.09e-05	9.56e-05	CbGpPWpGaD
Plerixafor—CXCR4—Disease—AKT1—epilepsy syndrome	3.73e-05	8.71e-05	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AKT1—epilepsy syndrome	2.61e-05	6.1e-05	CbGpPWpGaD
